Overview of Transplantation Therapeutics- A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs
Latest research report on "Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation".
View full press release